A Longitudinal Comparison of Antibodies to Epstein-Barr Virus and Clinical Parameters in Chronic Lymphocytic Leukemia and Chronic Myelocytic Leukemia

Elevated titers to the Epstein-Barr virus have previously been reported in a number of lymphoproliferative diseases, including Burkitt's lymphoma, infectious mononucleosis, and Hodgkin's disease. This study also demonstrates a significantly higher titer against EBV in a group of patients w...

Full description

Saved in:
Bibliographic Details
Published in:Blood 1971-10, Vol.38 (4), p.479-484
Main Authors: Levine, Paul H., Merrill, Deborah A., Bethlenfalvay, Nicholas C., Dabich, Lyubica, Stevens, David A., Waggoner, Deward E.
Format: Article
Language:English
Subjects:
Adult
Aged
Animals
Antibodies - analysis
Antigens
Female
Fluorescent Antibody Technique
Goats
Herpesviridae - immunology
Herpesvirus 4, Human - immunology
Humans
Immunodiffusion
Immunoglobulin G
Immunoglobulins - analysis
Leukemia, Lymphoid - immunology
Leukemia, Myeloid - immunology
Leukocyte Count
Male
Middle Aged
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Elevated titers to the Epstein-Barr virus have previously been reported in a number of lymphoproliferative diseases, including Burkitt's lymphoma, infectious mononucleosis, and Hodgkin's disease. This study also demonstrates a significantly higher titer against EBV in a group of patients with chronic lymphoproliferative disease (CLL) than in a group of patients with chronic myeloproliferative disease (CML) or normal individuals. No significant antibody changes were detected in the 20 CML patients or 23 of the 24 CLL patients who were followed for a period of time up to 5 yr. It appears that the elevated EBV titers seen in patients with CLL reflect an event or process occurring prior to the onset of disease or in the very early stages rather than a nonspecific rise paralleling the increase in total-body lymphocytes.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V38.4.479.479